Dr. Arun Kumar Khanna


As Chairman & Managing Director, Arun is the guiding light behind everything that Uth stands for. A Bachelors in Science from Jabalpur University , he is a veteran of the Pharma industry. In his career of more than 40 years he has been ascribed with creation of mega blockbuster brands, innovative marketing strategies to enhance in-clinic effectiveness, leadership grooming and development of work force among other things.

 He is recognized widely for his work for improving the quality of life of PLHIV ( People Living with HIV/AIDS) through TAAL (Treatment Adherence Advocacy and Literacy), in association with UNDP . TAAL provides uninhibited access to treatment ,medication at low cost and  counselling for patients.

He has been working relentlessly to improve access and availability of ARV’s (Anti Retrovirals) and other pharmaceutical products in the African and other pharmerging markets. As a Member of the CII- Africa Committee, this pursuit to deepen understanding and engagement between nations continues. As recognition of his contribution to the pharma industry, he was awarded a Ph.D. by Shri Venkateshwara university, Gajraula, Uttar Pradesh.

Arun started his career with Ranbaxy. He was associated with Alkem & Cadila and joined on the board of Emcure in 1995 and served on its Board for 20 years, as its COO.

Mr. Ajit Pai


Ajit is Managing Director at Plumeria Holdings, a leading global advisory and investment firm. Prior to Plumeria, he was Managing Director, Equity Research, at Stifel Financial and Thomas Weisel Partners. Over the past 17 years he has been involved with several hundred growth companies through various stages of their evolution. He has nurtured over a 100 companies from their early stages through IPOs or other exits – advising on strategy, driving the growth/monetization process, and engaging in multiple transactions for a significant number of these companies. Ajit has done his MBA with distinctions from the Yale School of Management, a Master’s degree in Architecture from the Yale School Architecture, and a Bachelor’s degree in Architecture from the School of Planning & Architecture, New Delhi.

Mr. Kunal Khanna

kunal Khanna

Kunal is the Executive Director and Co-founder of Vivaldis Health & Foods Private Limited.  Vivaldis is involved in small & large animal health product marketing.

He has over 13 years of experience of setting up and creating successful businesses across continents. He started his career in 2003 with Citibank India and then moved to London to help build their UK Private Banking operations. He went on to join GlaxoSmithKline (GSK) where he was responsible for Mergers and Acquisitions, based in Dubai. Thereafter he was with Emcure as Director-Business Development, responsible for the Middle East and Africa markets. Kunal has done his MBA from Symbiosis, Pune and London Business School, London.

Mr. Rajiv Gulati


Rajiv is the Co-founder of mChemist. Started in 2014, mChemist is a retail pharmacy delivering medicines at home. He has over 30 years experience in the pharmaceutical sphere. An alumnus of IIM Ahmedabad, Rajiv started his career with Ranbaxy. He served as CEO of Eli Lilly India and followed it up as Head – India-China Strategy and Global Anti-Counterfeiting Operations , based at Eli Lilly’s headquarters in the US. Upon his return to India he joined Ranbaxy as President -Global Pharma Business, before starting mChemist